Lycera Corporation

Zoetis Services LLC

Ah USA 42 LLC

Donald James Skalitzky

Thomas Daniel Aicher

Clarke Bentley Taylor

Peter Laurence Toogood

Chad A VanHuis

Graham M Kyne

Chad A Van Huis

Valerie Ann Vaillancourt

Richard Andrew Ewin

Timothy Allan Johnson

Nathan Anthony Logan Chubb

Alexander Ross Hurd

Michael P Curtis

Paul D Johnson

Rajendran Vairagoundar

Susan M K Sheehan

Fernando Padilla

Derek James Sheehan

Brian A Duclos

Sanjay Menon

John Adam Wendt

Susan Mary Kult Sheehan

William Howson

Michael Paul Curtis

Sanjay Rajagopal Menon

Nathan A L Chubb

The invention provides indazolyl thiadiazolamines and related compounds, pharmaceutical compositions, methods of inhibiting Rho-associated protein kinase, and methods of treating inflammatory disorders, immune disorders, fibrotic disorders, and other medical disorders using such compounds. An exemplary indazolyl thiadiazolamine compound is an N-(3-(5-((1H-indazol-5-yl)amino)-1,2,4-thiadiazol-3-yl)phenyl)-heteroaryl-carboxamide compound.

Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease

The invention provides pyrazolyl guanidine compounds that inhibit FF-ATPase, and methods of using pyrazolyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.

N-substituted pyrazolyl guanidine FF-ATPase inhibitors and therapeutic uses thereof

The invention provides benzenesulfonamido and related compounds, pharmaceutical compositions, methods of promoting ROR&#x3b3; activity, increasing the amount of IL-17 in a subject, and treating cancer using such benzenesulfonamido and related compounds.

Benzenesulfonamido and related compounds for use as agonists of ROR&#x3b3; and the treatment of disease

The invention provides indazole guanidine compounds that inhibit FF-ATPase, and methods of using indazole guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.

[object Object]

The present invention provides novel phenicol derivatives, their use for the treatment of infections in mammals, pharmaceutical compositions containing these novel compounds, and methods for the preparation of these compounds.

Phenicol antibacterials

This invention recites isoxazoline substituted azetidine derivatives of Formula (1) stereoisomers thereof, veterinarily acceptable salts thereof, compositions thereof, and their use as a parasiticide in mammals and birds. R, R, R, R, R, R, R, and n are as described herein.

Isoxazoline derivatives as antiparasitic agents

Growing community of inventors

Saline, MI, United States of America

Donald James Skalitzky